InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: was Gyro post# 8619

Thursday, 05/31/2007 9:58:40 AM

Thursday, May 31, 2007 9:58:40 AM

Post# of 30387
Gyro, Their patent does not detect cancer. It is a method of treating cancer using modified AFP. And yes, the fact that they are using modified AFP to treat cancer via RECAF validates RECAF as an indicatior of cancer.

What is does show however, Bocx is not going to be alone in therapeutics using RECAF.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.